If the timeline is adhered to, this clinical-stage company, focused on developing drugs for disorders concerned especially with the ear, nose, and throat, has an important catalyst coming up this quarter.
from RTT - Biotech http://ift.tt/2z9sjXh
via IFTTT
No comments:
Post a Comment